Journal Article
Carbapenem resistant Campylobacter jejuni bacteremia in a Bruton’s X-linked agammaglobulinemia patient
Ran Zhuo; Ramee L. Younes; Kevin Ward; Shangxin Yang
European Journal of Clinical Microbiology & Infectious Diseases · Vol. 43, Issue 12 · pp. 2459-2463 · 2024
Abstract
Immunocompromised patients are prone to recurrent Campylobacter infections. We report a case of recurrent multi-drug resistant Campylobactor jejuni bloodstream infections in a Bruton’s X-linked agammaglobulinemia patient with prolonged ertapenem treatment. The isolate from the fifth recurrence developed carbapenem resistance, which is associated with mutations in a porin gene porA , and promoter changes and duplication of chromosomal bla OXA-61 gene. Combination therapy using cefepime and doxycycline (later switched to moxifloxacin) cleared the infection.